Literature DB >> 21636641

Generation of induced pluripotent stem cells from urine.

Ting Zhou1, Christina Benda, Sarah Duzinger, Yinghua Huang, Xingyan Li, Yanhua Li, Xiangpeng Guo, Guokun Cao, Shen Chen, Lili Hao, Yau-Chi Chan, Kwong-Man Ng, Jenny Cy Ho, Matthias Wieser, Jiayan Wu, Heinz Redl, Hung-Fat Tse, Johannes Grillari, Regina Grillari-Voglauer, Duanqing Pei, Miguel A Esteban.   

Abstract

Forced expression of selected transcription factors can transform somatic cells into embryonic stem cell (ESC)-like cells, termed induced pluripotent stem cells (iPSCs). There is no consensus regarding the preferred tissue from which to harvest donor cells for reprogramming into iPSCs, and some donor cell types may be more prone than others to accumulation of epigenetic imprints and somatic cell mutations. Here, we present a simple, reproducible, noninvasive method for generating human iPSCs from renal tubular cells present in urine. This procedure eliminates many problems associated with other protocols, and the resulting iPSCs display an excellent ability to differentiate. These data suggest that urine may be a preferred source for generating iPSCs.
Copyright © 2011 by the American Society of Nephrology

Entities:  

Mesh:

Year:  2011        PMID: 21636641      PMCID: PMC3137570          DOI: 10.1681/ASN.2011010106

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

1.  Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

Authors:  Hassan Rahmoune; Paul W Thompson; Joanna M Ward; Chari D Smith; Guizhu Hong; John Brown
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system.

Authors:  A Dörrenhaus; J I Müller; K Golka; P Jedrusik; H Schulze; W Föllmann
Journal:  Arch Toxicol       Date:  2000-12       Impact factor: 5.153

3.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

4.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

6.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

Authors:  Alessandra Giorgetti; Nuria Montserrat; Trond Aasen; Federico Gonzalez; Ignacio Rodríguez-Pizà; Rita Vassena; Angel Raya; Stéphanie Boué; Maria Jose Barrero; Begoña Aran Corbella; Marta Torrabadella; Anna Veiga; Juan Carlos Izpisua Belmonte
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

7.  Generation of induced pluripotent stem cells from human cord blood.

Authors:  Alexandra Haase; Ruth Olmer; Kristin Schwanke; Stephanie Wunderlich; Sylvia Merkert; Christian Hess; Robert Zweigerdt; Ina Gruh; Johann Meyer; Stefan Wagner; Lars S Maier; Dong Wook Han; Silke Glage; Konstantin Miller; Philipp Fischer; Hans R Schöler; Ulrich Martin
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

8.  Reconstruction of tubular structures in three-dimensional collagen gel culture using proximal tubular epithelial cells voided in human urine.

Authors:  Chiyoko N Inoue; Norio Sunagawa; Tetsuji Morimoto; Shoko Ohnuma; Fumio Katsushima; Toshiyuki Nishio; Yoshiaki Kondo; Kazuie Iinuma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Sep-Oct       Impact factor: 2.416

9.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

10.  Efficient feeder-free episomal reprogramming with small molecules.

Authors:  Junying Yu; Kevin Fongching Chau; Maxim A Vodyanik; Jinlan Jiang; Yong Jiang
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

View more
  152 in total

1.  Reprogramming in suspension.

Authors:  Jiekai Chen; Duanqing Pei
Journal:  Nat Methods       Date:  2012-04-27       Impact factor: 28.547

Review 2.  Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.

Authors:  Xixi Du; Jack M Parent
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 3.  Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research?

Authors:  Cheryl Filippich; Ernst J Wolvetang; Bryan J Mowry
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

4.  Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine.

Authors:  Yuyu Chen; Rongping Luo; Yong Xu; Xiujuan Cai; Wuxian Li; Kuibi Tan; Jianrong Huang; Yong Dai
Journal:  Rheumatol Int       Date:  2013-02-22       Impact factor: 2.631

Review 5.  Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Authors:  I K Rony; A Baten; J A Bloomfield; M E Islam; M M Billah; K D Islam
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

6.  Disease Modeling To Understand the Pathomechanisms of Human Genetic Kidney Disorders.

Authors:  Elisa Molinari; John A Sayer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-05       Impact factor: 8.237

Review 7.  Harnessing the mesenchymal stem cell secretome for regenerative urology.

Authors:  Daniel Z Sun; Benjamin Abelson; Paurush Babbar; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2019-06       Impact factor: 14.432

8.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

9.  Generation of integration-free neural progenitor cells from cells in human urine.

Authors:  Lihui Wang; Linli Wang; Wenhao Huang; Huanxing Su; Yanting Xue; Zhenghui Su; Baojian Liao; Haitao Wang; Xichen Bao; Dajiang Qin; Jufang He; Wutian Wu; Kwok Fai So; Guangjin Pan; Duanqing Pei
Journal:  Nat Methods       Date:  2012-12-09       Impact factor: 28.547

10.  AP-1 activity is a major barrier of human somatic cell reprogramming.

Authors:  Yuting Liu; Jiangping He; Ruhai Chen; He Liu; Jocelyn Chen; Yujian Liu; Bo Wang; Lin Guo; Duanqing Pei; Jie Wang; Jing Liu; Jiekai Chen
Journal:  Cell Mol Life Sci       Date:  2021-06-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.